Entity
Description
  • Value proposition

    Engineering the future of drug discovery

    Antiverse is a Welsh techbio start-up specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to save lives.

    Headquartered in Cardiff, UK and with offices in Boston, MA, we combine state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics.

    Machine Learning, Antibodies, and Drug discovery

Corporate interactions BETA
Corporate TypeTweets Articles
Boehringer Ingelheim
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Other

31 Jan 2024


Sifted
Sifted
Newspaper Publishing
Sifted
Newspaper Publishing
Other

21 Oct 2023


Deep Science Ventures
Deep Science Ventures
Startup accelerator & VC, Venture Capital and Private Equity Principals
Deep Science Ventures
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

7 Mar 2023


Similar entities
Loading...
Loading...
Social network dynamics